CAJ | 학술논문

目的探讨中西医结合治疗乙肝肝纤维化的疗效。方法将98例乙肝肝纤维化患者随机分为观察组和对照组，每组各49例，对照组采用阿德福韦酯治疗，观察组在对照组的基础上采用乙肝抗纤汤治疗，并比较两组疗效。结果观察组患者肝功能3项指标与治疗前相比较（P<0.05），对照组 ATL、AST与治疗前相比较（P<0.05），观察组治疗后三项肝功能指标与对照组比较（P<0.05）。观察组治疗后的4项肝纤维化指标与治疗前比较（P<0.05)；对照组 HA、LN、PC-Ⅲ与治疗前比较（P<0.05)；观察组治疗后HA、LN、IV-C 与对照组比较（P<0.05)。结论中西医结合治疗乙肝肝纤维化，具有抗病毒，益气活血，疏肝健脾，有效改善肝功能及肝脏的形态，阻止病情进一步发展，提高了患者的生活质量。
목적탐토중서의결합치료을간간섬유화적료효。방법장98례을간간섬유화환자수궤분위관찰조화대조조，매조각49례，대조조채용아덕복위지치료，관찰조재대조조적기출상채용을간항섬탕치료，병비교량조료효。결과관찰조환자간공능3항지표여치료전상비교（P<0.05），대조조 ATL、AST여치료전상비교（P<0.05），관찰조치료후삼항간공능지표여대조조비교（P<0.05）。관찰조치료후적4항간섬유화지표여치료전비교（P<0.05)；대조조 HA、LN、PC-Ⅲ여치료전비교（P<0.05)；관찰조치료후HA、LN、IV-C 여대조조비교（P<0.05)。결론중서의결합치료을간간섬유화，구유항병독，익기활혈，소간건비，유효개선간공능급간장적형태，조지병정진일보발전，제고료환자적생활질량。
Objective To explore Integrative the ef icacy of the treatment of hepatitis B liver fibrosis. Methods 98 cases of hepatitis B in patients with liver fibrosis were randomly divided into observation group and control group, 49 cases for each group, the control group was treated by the adefovir dipivoxil, the observation group was treated by the hepatitis B Kangxian decoction on the basis of the control group, and compared the ef ects of the two groups. Results The three indicators of liver function in patients of the observation group were compared with before treatment (P<0.05), The ATL, AST of the control group were compared with before treatment (P<0.05), three liver function indicators in the observation group after treatment compared with control group (P<0.05). 4 liver fibrosis markers in the observation group after treatment compared with before treatment (P<0.05);the control group HA, LN, PC-Ⅲand treatment comparison (P<0.05);After treatment, HA, LN, IV-C compared with control group (P<0.05). Conclusion The Integrative Medicine treats the hepatitis B liver fibrosis, has the antiviral Yiqihuoxue, Shuganjianpi ef ectively improve liver function and liver morphology to prevent the disease from further development, improve the patient's quality of life.